|
⚲
|
| Keyboard |
| Reid Laurence
✚
|
|
|---|---|
| CIK # | 0001492749 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001492749] | |
| 4 | [0001492749] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Reid Laurence | |
| KalVista Pharmaceuticals Inc | |
| Metagenomi Therapeutics Inc | |
| Decibel Therapeutics Inc | |
| Alnylam Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
KalVista Pharmaceuticals Inc KALV
Stock Option (Right to Buy) · derivative
|
2024-11-23 | Grant | 17,000 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Stock Option (right to buy) · derivative
|
2023-09-25 | Disposed to issuer | 187,500 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2023-09-25 | Disposed to issuer | 220,849 | ||
|
Decibel Therapeutics Inc DBTX
Stock Option (right to buy) · derivative
|
2023-09-25 | Disposed to issuer | 1,072,539 | ||
|
Decibel Therapeutics Inc DBTX
Stock Option (right to buy) · derivative
|
2023-09-25 | Disposed to issuer | 72,000 | ||
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2023-03-16 | Grant | 195,000 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Stock Options (right to buy) · derivative
|
2023-03-16 | Grant | 72,000 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Stock Options (right to buy) · derivative
|
2022-02-25 | Grant | 187,500 | $0.00 | |
|
Decibel Therapeutics Inc DBTX
Common Stock
|
2021-09-15 | Buy | 10,000 | $7.64 | 76,400 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-12-31 | Option exercise | 17,000 | $15.99 | 271,830 |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (Right to Buy) · derivative
|
2014-12-31 | Option exercise | 17,000 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-12-31 | Tax withheld | 2,802 | $97.00 | 271,794 |
|
Alnylam Pharmaceuticals Inc ALNY
Performance Based Stock Option (right to buy) · derivative
|
2014-12-12 | Grant | 6,667 | $0.00 | |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Option exercise | 3,639 | $15.99 | 58,188 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Option exercise | 2,500 | $7.10 | 17,750 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Option exercise | 3,861 | $9.14 | 35,290 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Sell | 102 | $91.79 | 9,363 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Sell | 5,413 | $90.30 | 488,794 |
|
Alnylam Pharmaceuticals Inc ALNY
Common Stock
|
2014-11-18 | Sell | 4,485 | $91.08 | 408,494 |
|
Alnylam Pharmaceuticals Inc ALNY
Stock Option (Right to Buy) · derivative
|
2014-11-18 | Option exercise | 3,861 | $0.00 | |
| showing 20 of 59 most recent transactions | |||||